Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Circulating Tumor DNA on Early Cancer Detection and Evaluation of STAS in Patients With Ground Glass Opacities

NCT05187767 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT05187767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05187767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Circulating Tumor DNA on Early Cancer Detection and Evaluation of STAS in Patients With Ground Glass Opacities
Lead sponsor
University of Roma La Sapienza
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2022
Completion date
October 31, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor cell, lung cancer, spreading of tumor